Document is current
Any future updates will be listed below
-
Authors
Mulvany, Monique
Wermter, Ellen
Lavender, Maggie
Merius, Heidy
Martin, Cecile
Burns, Amber
Simmons, Jamie
-
Funding
Funding for this research was provided by:
Avadel Pharmaceuticals
- License Information
-
More Information
Article History
Received: 5 December 2025
Accepted: 5 March 2026
First Online: 28 March 2026
Declarations
:
: Monique Mulvany has served as a consultant and speaker for Avadel Pharmaceuticals. Ellen Wermter has served as a consultant, speaker, and/or on advisory boards for Avadel Pharmaceuticals, Harmony Biosciences, Jazz Pharmaceuticals, and Axsome Therapeutics. Maggie Lavender has served as a consultant, speaker, and/or has received consulting fees for participation on advisory boards for Avadel Pharmaceuticals, Harmony Biosciences, Jazz Pharmaceuticals, and Axsome Therapeutics. Heidy Merius has served as a consultant and on advisory boards for Avadel Pharmaceuticals. Cecile Martin has received consulting fees for participation on advisory boards for Avadel Pharmaceuticals, Axsome Therapeutics, and Harmony Biosciences and has served on speakers bureaus for Avadel Pharmaceuticals and Jazz Pharmaceuticals. Amber Burns has served as a consultant, speaker, and/or on advisory boards for Avadel Pharmaceuticals. Jamie Simmons has served on advisory boards for Avadel Pharmaceuticals.
: Formal ethical approval was not sought for this modified Delphi process. All participants provided written consent of their approval to participate in the Delphi process and author the present manuscript.
